Tuesday, 02 January 2024 12:17 GMT

Automated Sample Preparation Technology Market Top Players, Segments & Regional Trends By 2034


(MENAFN- Straits Research) Introduction

Straits Research released its highly anticipated report, “Global Automated Sample Preparation Technology Market Size & Outlook, 2026-2034”. According to the study, the market size is valued at USD 1.35 billion in 2025 and is anticipated to grow till USD 3.10 billion by 2034, growing at a CAGR of 9.68% from 2026-2034.

Market Dynamics

The automated sample preparation technology market is expanding steadily as laboratories across research, clinical, and biopharmaceutical environments continue adopting systems that streamline extraction, purification, and assay setup. A key driver for this market is the increasing scale of molecular testing programs that require uniform sample quality across large batches. As sequencing, biomarker studies, and routine diagnostics continue to expand in volume, laboratories rely on automation to maintain consistent outputs, reduce operator variation, and support faster turnaround times. This shift toward larger and more complex workflows strengthens demand for platforms that can handle diverse sample types with predictable performance.

A central restraint arises from integration challenges when laboratories attempt to combine instruments, consumables, and software from different vendors. Variations in pipetting formats, cartridge layouts, and communication interfaces lead to workflow adjustments that slow implementation. These compatibility gaps require additional validation efforts and may discourage laboratories from upgrading or expanding automation systems. Furthermore, training requirements and initial configuration processes can limit adoption among facilities with limited technical resources.

An emerging opportunity is the rapid expansion of decentralized molecular testing centers, including regional laboratories, satellite hospital units, and smaller research clusters, that are increasingly seeking compact automation platforms. These centers aim to introduce molecular workflows without extensive infrastructure and benefit from portable extraction units, simplified software interfaces, and consumables optimized for low- to medium-throughput operations. As more institutions pursue localized testing to improve accessibility and reduce dependency on central facilities, demand for automation suited to distributed environments is expected to increase, creating new growth pathways for technology providers.

Market Highlights

  • Product & Service: Based on product & service, the Instruments segment held the highest revenue share of 32.63% in 2025.
  • Application: Based on application, the Clinical Diagnostics segment dominated the market with 34.56% in 2025.
  • End Use: By end use, the Pharmaceutical and Biotechnology Companies segment held the largest market share of 41.24% in 2025.
  • Regional Insights: North America held a dominant share of the global market, accounting for 45.84% in 2025.

Competitive Players

  • AutoGen, Inc.
  • Zymo Research Corporation
  • Aurora Biomed Inc.
  • Hamilton Company
  • Agilent Technologies, Inc.
  • Hoffmann-La Roche Ltd
  • Eppendorf SE
  • Promega Corporation
  • Bio-Rad Laboratories, Inc.
  • MGI Tech Co., Ltd.
  • Analytik Jena GmbH+Co. KG
  • Thermo Fisher Scientific Inc.
  • Tecan Trading AG
  • QIAGEN
  • PerkinElmer
  • Others

    Recent Developments

    April 2025: QIAGEN unveiled a strategic initiative to introduce three new sample preparation instruments: QIAsymphony Connect, QIAsprint Connect, and QIAmini by 2026, designed to advance laboratory automation, boost workflow efficiency, and cater to both high and low throughput laboratory needs.

    Segmentation

  • By Product & Service (2026-2034)
  • Instruments
  • Consumables
  • Software & Services
  • By Application (2026-2034)
  • Clinical Diagnostics
  • Genomics & Next-generation Sequencing
  • Proteomics & Metabolomics
  • Drug Discovery & Development
  • Others
  • By End Use (2026-2034)
  • Pharmaceutical & Biotechnology Companies
  • Academic & Research Institutes
  • Hospitals & Diagnostic Laboratories
  • Others

    Chat with us on WhatsApp

    MENAFN26122025004597010339ID1110526819



  • Straits Research

    Legal Disclaimer:
    MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.

    Search